Ethan S. Weiner

1.4k total citations
16 papers, 1.1k citations indexed

About

Ethan S. Weiner is a scholar working on Rheumatology, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, Ethan S. Weiner has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 6 papers in Pharmacology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Ethan S. Weiner's work include Inflammatory mediators and NSAID effects (6 papers), Systemic Sclerosis and Related Diseases (5 papers) and Inflammatory Myopathies and Dermatomyositis (4 papers). Ethan S. Weiner is often cited by papers focused on Inflammatory mediators and NSAID effects (6 papers), Systemic Sclerosis and Related Diseases (5 papers) and Inflammatory Myopathies and Dermatomyositis (4 papers). Ethan S. Weiner collaborates with scholars based in United States, Canada and Sweden. Ethan S. Weiner's co-authors include Naomi F. Rothfield, William C. Earnshaw, Bonnie J. Bordwell, Jean‐Luc Senécal, P. Johnson, Kenneth M. Verburg, John B. Cheng, Jon M. Hanifin, Sai C. Chan and William R. Henderson and has published in prestigious journals such as The American Journal of Medicine, The American Journal of Cardiology and Journal of Investigative Dermatology.

In The Last Decade

Ethan S. Weiner

16 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ethan S. Weiner United States 12 382 346 248 240 229 16 1.1k
István Csípő Hungary 18 281 0.7× 425 1.2× 269 1.1× 41 0.2× 43 0.2× 53 1.1k
Angéla Pákozdi United Kingdom 12 288 0.8× 205 0.6× 94 0.4× 52 0.2× 88 0.4× 23 736
Éric Gagné Canada 17 124 0.3× 149 0.4× 119 0.5× 67 0.3× 78 0.3× 32 1.2k
Won Tae Chung South Korea 20 126 0.3× 475 1.4× 134 0.5× 80 0.3× 24 0.1× 59 914
Hua Zhong China 16 90 0.2× 121 0.3× 90 0.4× 37 0.2× 89 0.4× 32 741
Kohsuke Masutani Japan 17 350 0.9× 293 0.8× 97 0.4× 35 0.1× 36 0.2× 31 1.5k
Tan Em United States 8 148 0.4× 165 0.5× 92 0.4× 31 0.1× 41 0.2× 13 728
R Coda Italy 15 82 0.2× 70 0.2× 62 0.3× 71 0.3× 22 0.1× 44 1.2k
N Buyssens Belgium 19 71 0.2× 50 0.1× 121 0.5× 70 0.3× 22 0.1× 57 1.1k
M Seishima Japan 12 335 0.9× 207 0.6× 80 0.3× 28 0.1× 25 0.1× 28 946

Countries citing papers authored by Ethan S. Weiner

Since Specialization
Citations

This map shows the geographic impact of Ethan S. Weiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ethan S. Weiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ethan S. Weiner more than expected).

Fields of papers citing papers by Ethan S. Weiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ethan S. Weiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ethan S. Weiner. The network helps show where Ethan S. Weiner may publish in the future.

Co-authorship network of co-authors of Ethan S. Weiner

This figure shows the co-authorship network connecting the top 25 collaborators of Ethan S. Weiner. A scholar is included among the top collaborators of Ethan S. Weiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ethan S. Weiner. Ethan S. Weiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
White, William B., Christine R. West, Jeffrey Borer, et al.. (2006). Risk of Cardiovascular Events in Patients Receiving Celecoxib: A Meta-Analysis of Randomized Clinical Trials. The American Journal of Cardiology. 99(1). 91–98. 155 indexed citations
2.
White, William B., Jeffrey Borer, Philip B. Gorelick, et al.. (2006). CARDIOVASCULAR EVENTS IN CLINICAL TRIALS INVOLVING OVER 41,000 PATIENTS EVALUATING THE CYCLOOXYGENASE-2 INHIBITOR CELECOXIB. JCR Journal of Clinical Rheumatology. 12(Supplement). S21–S21. 2 indexed citations
3.
Otterness, Ivan G., et al.. (2001). An analysis of 14 molecular markers for monitoring osteoarthritis. Relationship of the markers to clinical end-points. Osteoarthritis and Cartilage. 9(3). 224–231. 56 indexed citations
4.
Verburg, Kenneth M., Timothy J. Maziasz, Ethan S. Weiner, et al.. (2001). COX-2???Specific Inhibitors: Definition of a New Therapeutic Concept. American Journal of Therapeutics. 8(1). 49–64. 43 indexed citations
5.
Otterness, Ivan G., et al.. (2000). An analysis of 14 molecular markers for monitoring osteoarthritis: segregation of the markers into clusters and distinguishing osteoarthritis at baseline. Osteoarthritis and Cartilage. 8(3). 180–185. 92 indexed citations
6.
Hanifin, Jon M., Sai C. Chan, John B. Cheng, et al.. (1996). Type 4 Phosphodiesterase Inhibitors Have Clinical and In Vitro Anti-inflammatory Effects in Atopic Dermatitis. Journal of Investigative Dermatology. 107(1). 51–56. 188 indexed citations
7.
Otterness, Ivan G., Archie C. Swindell, A. Robin Poole, et al.. (1995). An examination of some molecular markers in blood and urine for discriminating patients with osteoarthritis from healthy individuals. Acta Orthopaedica Scandinavica. 66(sup266). 148–150. 6 indexed citations
8.
Loose, Leland D., et al.. (1993). Reduction of Acute-Phase Proteins with Tenidap Sodium, a Cytokine-Modulating Anti-Rheumatic Drug. Lara D. Veeken. 32(suppl 3). 19–25. 41 indexed citations
9.
Yaneva, Mariana, Ethan S. Weiner, A. L. Parke, et al.. (1992). Autoantibodies in patients with primary pulmonary hypertension: Association with anti-Ku. The American Journal of Medicine. 93(3). 307–312. 89 indexed citations
10.
Weiner, Ethan S., Sabine Hildebrandt, Jean‐Luc Senécal, et al.. (1991). Prognostic significance of anticentromere antibodies and anti–topoisomerase i antibodies in Raynaud's disease. A prospective study. Arthritis & Rheumatism. 34(1). 68–77. 125 indexed citations
11.
Hildebrandt, Sabine, et al.. (1991). Idiotypic Analysis of Human Anticentromere Autoantibodies. Autoimmunity. 9(2). 131–140. 5 indexed citations
12.
Hildebrandt, Sabine, et al.. (1990). The igg, igm, and iga isotypes of anti‐topoisomerase i and anticentromere autoantibodies. Arthritis & Rheumatism. 33(5). 724–727. 32 indexed citations
13.
Hildebrandt, Sabine, Ethan S. Weiner, Jean‐Luc Senécal, et al.. (1990). Autoantibodies to topoisomerase I (Scl-70): Analysis by gel diffusion, immunoblot, and enzyme-linked immunosorbent assay. Clinical Immunology and Immunopathology. 57(3). 399–410. 43 indexed citations
14.
Weiner, Ethan S., et al.. (1988). Clinical associations of anticentromere antibodies and antibodies to topoisomerase i. a study of 355 patients. Arthritis & Rheumatism. 31(3). 378–385. 172 indexed citations
15.
Rothfield, Naomi F., David Whitaker, Bonnie J. Bordwell, et al.. (1987). Detection of anticentromere antibodies using cloned autoantigen cenp‐Bl. Arthritis & Rheumatism. 30(12). 1416–1419. 51 indexed citations
16.
Weiner, Ethan S.. (1979). Localized Endotracheal Oxalosis Probably Secondary to Aspiration of Rhubarb. Archives of Internal Medicine. 139(5). 602–602. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by István Csípő Breakdown of academic impact, for papers by Angéla Pákozdi Breakdown of academic impact, for papers by Éric Gagné Breakdown of academic impact, for papers by Won Tae Chung Breakdown of academic impact, for papers by Hua Zhong Breakdown of academic impact, for papers by Kohsuke Masutani Breakdown of academic impact, for papers by Tan Em Breakdown of academic impact, for papers by R Coda Breakdown of academic impact, for papers by N Buyssens Breakdown of academic impact, for papers by M Seishima
Rankless by CCL
2026